Keywords: fda, backs, new, dose, solvay, prometrium, food
FDA backs new dose of Solvay's Prometrium
Article | 21 October 1999
The US Food and Drug Administration has approved SolvayPharmaceuticals' Prometrium (micronized progesterone) in a new 200mg strength. Prometrium, which is ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
